Add To Watchlist
Share URL
AbbVie Inc.
ABBV: NYSELowest reading is at 14 out of 100. All scores are out of 100.
About The Company
CEO
Mr. Scott T. Reents
Market Cap
467.12 Billion USD
Sector
Healthcare
Website
https://www.abbvie.comLast Update
27/09/2026, 09:19:45
Description
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
Read More
Strongest readings
- ✔Debt is low at 0.00 times equity
- ✔Return on capital employed of 16.63% is above the market average of 10.00%
- ✔Dividend growth averages 5.34% per year
Weakest readings
- ✘Price-to-earnings of 74.5 is above the market average of 19.6
- ✘A high share of income is paid out as dividend (189.83%)
- ✘Revenue is growing at 3.71% per year while free cashflow is falling
- ✘Priced well above the cashflow it produces (value score 14 out of 100)
- ✘The current price sits above estimated fair value (margin of safety -73.71%)
Key Figures
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
| ✘ | Price / earnings (TTM) | 74.46x | 19.60x | |
| ✘ | Margin of safety (DCF) | -73.71% | 17.95% | |
| ✘ | Revenue growth (5y average) | 3.71% | 10.97% | |
| ✔ | Dividend yield (TTM) | 2.56% | 1.85% | |
| ✘ | Share count, per year | 1.19% | 0.00% | |
| ✔ | Return on capital employed | 16.63% | 10.00% |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
Valuation
14 / 100Priced above the market on most measures.
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
| ✘ | Price / earnings | 74.46x | 19.60x | |
| ✘ | Free cashflow yield | 3.90% | 4.70% | |
| Price / earnings growth | N/A | 1.50x | ||
| Price / book | N/A | — | ||
| ✘ | Margin of safety | -73.71% | 17.95% |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
- ✘Estimated intrinsic value of 69.50 USD is below the current price of 264.34 USD
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Estimated Fair Value: 192 USD ✘
Current Price: 264.3 USD
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated fair value for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel for the impact this has on longterm investment returns and find a margin of safety you are comfortable with.
Growth
22 / 100Growing more slowly than the market on most measures.
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
| ✘ | Revenue growth | 3.71% | 10.97% | |
| ✘ | Earnings growth | -1.25% | 14.48% | |
| ✘ | Cashflow growth | -0.09% | 12.35% |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
- ✔Revenue growth has improved this year (10.39% against a five year average of 3.71%)
- ✔Earnings growth has improved this year (69.05% against a five year average of -1.25%)
- ✘Free cashflow growth has slowed this year
- ✘Revenue is growing at 3.71% per year while free cashflow is falling at 0.09% per year
Health
45 / 100Balance sheet is stretched on several measures.
Measured on Leverage and capital, Funding and liquidity, Earnings quality.
| Status | Metric | Value | Reading | Threshold |
|---|---|---|---|---|
| ✘ | Altman-Z score | 2.58 | 3.00 | |
| ✔ | Piotroski score | 8.00 | 5.00 | |
| ✔ | Debt / equity | 0.00x | 0.80x | |
| ✘ | Current ratio | 0.67x | 1.00x | |
| ✔ | Interest coverage | 5.21x | 2.50x | |
| ✔ | Free cashflow / debt | 0.27x | 0.15x | |
| ✘ | Debt / capital | 1.05x | 1.00x |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
Dividend
49 / 100Cover is thin on at least one measure.
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
| ✔ | Dividend yield | 2.56% | 1.85% | |
| ✔ | Dividend growth | 5.73% | 0.00% | |
| ✘ | Payout ratio (earnings) | 189.83% | 40.00% | |
| ✘ | Payout ratio (cashflow) | 65.78% | 65.00% | |
| ✔ | Worst year, last 5 years | 4.55% | -2.00% |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
- ✔Dividend growth has been accelerating recently
Management
56 / 100Returns on capital are at or above the market.
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
| Return on equity | N/A | 15.00% | ||
| ✔ | Return on capital employed | 16.63% | 10.00% | |
| Return on assets | 3.15% | — | ||
| Free cashflow return on capital | 19.65% | — | ||
| ✔ | Return on capital, 5y change | 0.34% | 0.00% | |
| ✘ | Share count, per year | 1.19% | 0.00% | |
| ✔ | Share count, recent | -0.11% | 0.00% | |
| ✘ | Realized buyback return | -93.44% | 0.00% | |
| Goodwill erosion / equity | N/A | 2.00% | ||
| Price volatility, 5 year | 22.77% | — |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
- ✔New shares were issued while the value score was 14 out of 100
- ✘Dividends were raised while earnings fell (dividend 5.34% per year, earnings -1.25% per year)
Analysts
not enough data| Status | Metric | Value | Reading | Neutral |
|---|---|---|---|---|
| Analyst opinion score | N/A | 50 |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
Financial History
Annual figures across the full reporting history we hold.
Market Peers
ABBV
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
See 35+ Years Annual ReportsOther Information
Company Name
AbbVie Inc.
Currency
USD
Beta
0.281
Vol Avg
5189241
Ceo
Mr. Scott T. Reents
Cik
0001551152
Cusip
Exchange
NYSE
Full Time Employees
57000
Industry
Drug Manufacturers - General
Sector
Healthcare
Ipo Date
Address
1 North Waukegan Road
City
North Chicago
State
IL
Country
United States
Zip
60064-6400
Phone
847 932 7900
Analysis Last Updated
27/09/2026, 09:19:45
Financial data compiled from SEC EDGAR filings and Yahoo Finance.